- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Vitrea sparks Vital Images results
Sales of its Vitrea 3-D visualization workstation helped Vital Images report sharply higher revenues for its first quarter (end-March), although the company’s net loss grew as well. For the period, the Minneapolis company posted sales of $766,000,
Sales of its Vitrea 3-D visualization workstation helped Vital Images report sharply higher revenues for its first quarter (end-March), although the companys net loss grew as well. For the period, the Minneapolis company posted sales of $766,000, compared with revenues of $156,000 in the first quarter of 1997. Vitrea began shipping in October, and in the most recent period contributed $488,000 to Vital Images revenues.
The companys net loss for the first quarter was $1.1 million, compared with a net loss of $873,000 for the first quarter of 1997. The net loss for the most recent period included a charge of $180,000 in connection with the departure of Vital Images former CEO, Andrew Weiss (SCAN 2/18/98).
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
